Insulin Pump Market Growth Forecast Report 2024- 2032

Global Insulin Pump Market Analysis

Market Size and Growth: The Global Insulin Pump Market is expected to reach around US$ 11.12 Billion by 2032, growing from US$ 4.63 Billion in 2023, with a projected CAGR of 10.23% from 2024 to 2032.

Market Overview: Insulin pumps are wearable medical devices that supply a continuous flow of rapid-acting insulin underneath the skin. They are an alternative to multiple daily injection (MDI) insulin therapy for people with diabetes who require insulin to manage the condition. The technology for insulin pumps is rapidly evolving, with most pumps being small, computerized devices roughly the size of a juice box or a deck of cards.

Market Drivers:

  • Technological Advancements: The continuous evolution of insulin pump technology is a significant driver of market growth, offering patients more precise dosing and the ability to continuously monitor blood glucose levels.
  • Increasing Diabetes Prevalence: The rising prevalence of diabetes globally, including both type 1 and type 2 diabetes, is driving the demand for insulin pumps as an effective treatment option.
  • Patient Preference for Insulin Pump Therapy: Studies have shown that patients often prefer insulin pump therapy over traditional insulin injection therapy, citing benefits such as better glucose control and improved quality of life.

Market Trends:

  • Rapid Adoption of Insulin Pump Therapy: A survey found that insulin pump adoption increased by 21% in 2021, reflecting a growing trend towards the use of insulin pumps for diabetes management.
  • Growing Awareness and Acceptance: Studies have shown high levels of patient satisfaction with insulin pump therapy, with many patients reporting improved outcomes and a decrease in hypoglycemic episodes.
  • Expansion in Emerging Markets: Emerging markets such as India are seeing significant growth in the insulin pump market, driven by increasing diabetes prevalence and growing awareness of the benefits of insulin pump therapy.


Request a free sample copy of the report:


Key Players: Major companies in the Global Insulin Pump Market include Medtronic, Insulet Corporation, Tandem Diabetes Care, Roche, Insulet Corp., Ypsomed Holding AG, and Microtech Medical.

Recent Developments

  • Abbott and Tandem Diabetes Care: Revealed that the t: slim X2 insulin pump featuring Control-IQ technology is the inaugural automated insulin delivery (AID) system to incorporate the recently launched FreeStyle Libre 2 Plus sensor, Abbott’s latest continuous glucose monitoring (CGM) innovation.
  • Tandem Diabetes Care: Finalized its acquisition of AMF Medical, the maker of the Sigi patch pump for insulin delivery, expanding its product portfolio in the insulin pump market.
  • Insulet Corporation: Acquired assets related to Bigfoot Biomedical’s pump-based automated insulin delivery (AID) technologies, enhancing its position in the AID therapy market.
  • ViCentra B.V.: Unveiled a Hybrid closed-loop system for automated insulin delivery in partnership with Diabeloop DBLG1 control software and Dexcom G6 CGM sensor, improving users’ Time in Range glucose values.

Market Breakdown


  1. Tethered Pumps
  2. Patch Pumps
  3. Consumables


  1. Type 1 Diabetes
  2. Type 2 Diabetes


  1. Insulin Reservoirs
  2. Infusion Sets
  3. Infusion Set Insertion Devices


  1. Hospitals and Clinics
  2. Home Care
  3. Others


  1. North America
    • United States
    • Canada
  2. Europe
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Belgium
    • Netherlands
    • Turkey
  3. Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
    • Malaysia
    • Indonesia
    • Australia
    • New Zealand
  4. Latin America
    • Brazil
    • Mexico
    • Argentina
  5. Middle East & Africa
    • Saudi Arabia
    • United Arab Emirates
    • South Africa


The Global Insulin Pump Market is experiencing significant growth driven by technological advancements, increasing diabetes prevalence, and patient preference for insulin pump therapy. Market trends include rapid adoption of insulin pump therapy, growing awareness and acceptance, and expansion in emerging markets. Major companies are introducing innovative products and technologies to cater to the evolving market demands.


About the Company:


Renub Research is a Market Research and Consulting Company. We have more than 14 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.Top of Form

Related Articles

Leave a Reply

Back to top button